Octave Specialty Group Inc: Form 10-Q for the period ended Mar 31, 2025
Filed with the SEC on May 12, 2025 and accepted by EDGAR at May 12, 2025, 17:09 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2025-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2025-01-01 to 2025-03-31 | $36.8m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest expense | 3 months2025-01-01 to 2025-03-31 | $5.5m | us-gaap:InterestExpense |
| Income tax | 3 months2025-01-01 to 2025-03-31 | −$617.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2025-01-01 to 2025-03-31 | −$44.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2025-01-01 to 2025-03-31 | −$1.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2025-01-01 to 2025-03-31 | −$1.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2025-01-01 to 2025-03-31 | 47,313,012 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2025-01-01 to 2025-03-31 | −$12.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2025-03-31 | $34.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Total assets | At period end2025-03-31 | $8.25bn | us-gaap:Assets |
| Total liabilities | At period end2025-03-31 | $7.04bn | us-gaap:Liabilities |
| Short-term borrowings | At period end2025-03-31 | $150.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2025-03-31 | $852.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000874501-25-000086. Last ingested by Listed: Oct 30, 2026, 12:35 ET. Listed shows no prices and gives no investment advice.